Advanced basal cell carcinoma, the hedgehog pathway, and treatment options – role of smoothened inhibitors

le Fecher, Leslie A, Sharfman, William H
Foilsithe in Biologics (2015)

Ipilimumab and Its Toxicities: A Multidisciplinary Approach

le Fecher, Leslie A., Agarwala, Sanjiv S., Hodi, F. Stephen, Weber, Jeffrey S.
Foilsithe 2013

Metastatic melanoma with diffuse melanosis histologically after stable response to talimogene laherparepvec therapy

le Rizzo, Jason M., Fecher, Leslie A., Chan, May P., Durham, Alison B.
Foilsithe in JAAD Case Rep (2018)

Metastatic Merkel cell carcinoma response to nivolumab

le Walocko, Frances M., Scheier, Benjamin Y., Harms, Paul W., Fecher, Leslie A., Lao, Christopher D.
Foilsithe in J Immunother Cancer (2016)

Erratum to: Metastatic Merkel cell carcinoma response to nivolumab

le Walocko, Frances M., Scheier, Benjamin Y., Harms, Paul W., Fecher, Leslie A., Lao, Christopher D.
Foilsithe in J Immunother Cancer (2017)

An adolescent with uveal melanoma and BAP1 tumor predisposition syndrome

le Young, Kelly Z., Fossum, Sara L., Lowe, Lori, Else, Tobias, Fecher, Leslie A., Demirci, Hakan, Cha, Kelly B.
Foilsithe in JAAD Case Rep (2020)

Acute visual loss after ipilimumab treatment for metastatic melanoma

le Wilson, Melissa A., Guld, Kelly, Galetta, Steven, Walsh, Ryan D., Kharlip, Julia, Tamhankar, Madhura, McGettigan, Suzanne, Schuchter, Lynn M., Fecher, Leslie A.
Foilsithe in J Immunother Cancer (2016)

Diverse cutaneous side effects associated with BRAF inhibitor therapy: A clinicopathologic study

le Chu, Emily Y., Wanat, Karolyn A., Miller, Christopher J., Amaravadi, Ravi K., Fecher, Leslie A., Brose, Marcia S., McGettigan, Suzanne, Giles, Lydia R., Schuchter, Lynn M., Seykora, John T., Rosenbach, Misha
Foilsithe in J Am Acad Dermatol (2012)

Collapse of the CD27+ B cell compartment associated with systemic plasmacytosis in patients with advanced melanoma and other cancers

le Carpenter, Erica L., Mick, Rosemarie, Rech, Andrew J., Beatty, Gregory L., Colligon, Theresa A., Rosenfeld, Myrna R., Kaplan, David E., Chang, Kyong-Mi, Domchek, Susan M., Kanetsky, Peter A., Fecher, Leslie A., Flaherty, Keith T., Schuchter, Lynn M., Vonderheide, Robert H.
Foilsithe 2009

Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regression

le Lin, Heng, Wei, Shuang, Hurt, Elaine M., Green, Michael D., Zhao, Lili, Vatan, Linda, Szeliga, Wojciech, Herbst, Ronald, Harms, Paul W., Fecher, Leslie A., Vats, Pankaj, Chinnaiyan, Arul M., Lao, Christopher D., Lawrence, Theodore S., Wicha, Max, Hamanishi, Junzo, Mandai, Masaki, Kryczek, Ilona, Zou, Weiping
Foilsithe in J Clin Invest (2018)

Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regression

le Lin, Heng, Wei, Shuang, Hurt, Elaine M., Green, Michael D., Zhao, Lili, Vatan, Linda, Szeliga, Wojciech, Herbst, Ronald, Harms, Paul W., Fecher, Leslie A., Vats, Pankaj, Chinnaiyan, Arul M., Lao, Christopher D., Lawrence, Theodore S., Wicha, Max, Hamanishi, Junzo, Mandai, Masaki, Kryczek, Ilona, Zou, Weiping
Foilsithe in J Clin Invest (2018)

Phase II Study of the MEK1/MEK2 Inhibitor Trametinib in Patients With Metastatic BRAF-Mutant Cutaneous Melanoma Previously Treated With or Without a BRAF Inhibitor

le Kim, Kevin B., Kefford, Richard, Pavlick, Anna C., Infante, Jeffrey R., Ribas, Antoni, Sosman, Jeffrey A., Fecher, Leslie A., Millward, Michael, McArthur, Grant A., Hwu, Patrick, Gonzalez, Rene, Ott, Patrick A., Long, Georgina V., Gardner, Olivia S., Ouellet, Daniele, Xu, Yanmei, DeMarini, Douglas J., Le, Ngocdiep T., Patel, Kiran, Lewis, Karl D.
Foilsithe in J Clin Oncol (2013)

Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma

le Rangwala, Reshma, Leone, Robert, Chang, Yunyoung C, Fecher, Leslie A, Schuchter, Lynn M, Kramer, Amy, Tan, Kay-See, Heitjan, Daniel F, Rodgers, Glenda, Gallagher, Maryann, Piao, Shengfu, Troxel, Andrea B, Evans, Tracey L, DeMichele, Angela M, Nathanson, Katherine L, O’Dwyer, Peter J, Kaiser, Jonathon, Pontiggia, Laura, Davis, Lisa E, Amaravadi, Ravi K
Foilsithe 2014

Combined MTOR and autophagy inhibition: Phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma

le Rangwala, Reshma, Chang, Yunyoung C, Hu, Janice, Algazy, Kenneth M, Evans, Tracey L, Fecher, Leslie A, Schuchter, Lynn M, Torigian, Drew A, Panosian, Jeffrey T, Troxel, Andrea B, Tan, Kay-See, Heitjan, Daniel F, DeMichele, Angela M, Vaughn, David J, Redlinger, Maryann, Alavi, Abass, Kaiser, Jonathon, Pontiggia, Laura, Davis, Lisa E, O’Dwyer, Peter J, Amaravadi, Ravi K
Foilsithe 2014

Activity of the MEK Inhibitor Trametinib (GSK1120212) in Advanced Melanoma in a Phase I, Dose-escalation Trial

le Falchook, Gerald S, Lewis, Karl D, Infante, Jeffrey R, Gordon, Michael S, Vogelzang, Nicholas J, DeMarini, Douglas J, Sun, Peng, Moy, Christopher, Szabo, Stephen A., Roadcap, Lori T, Peddareddigari, Vijay G R, Lebowitz, Peter F, Le, Ngocdiep T, Burris, Howard A, Messersmith, Wells A, O'Dwyer, Peter J, Kim, Kevin B., Flaherty, Keith, Bendell, Johanna C., Gonzalez, Rene, Kurzrock, Razelle, Fecher, Leslie A
Foilsithe 2012

Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study

le Rivera, Donna R., Peters, Solange, Panagiotou, Orestis A., Shah, Dimpy P., Kuderer, Nicole M., Hsu, Chih-Yuan, Rubinstein, Samuel M., Lee, Brendan J., Choueiri, Toni K., de Lima Lopes, Gilberto, Grivas, Petros, Painter, Corrie A., Rini, Brian I., Thompson, Michael A., Arcobello, Jonathan, Bakouny, Ziad, Doroshow, Deborah B., Egan, Pamela C., Farmakiotis, Dimitrios, Fecher, Leslie A., Friese, Christopher R., Galsky, Matthew D., Goel, Sanjay, Gupta, Shilpa, Halfdanarson, Thorvardur R., Halmos, Balazs, Hawley, Jessica E., Khaki, Ali Raza, Lemmon, Christopher A., Mishra, Sanjay, Olszewski, Adam J., Pennell, Nathan A., Puc, Matthew M., Revankar, Sanjay G., Schapira, Lidia, Schmidt, Andrew, Schwartz, Gary K., Shah, Sumit A., Wu, Julie T., Xie, Zhuoer, Yeh, Albert C., Zhu, Huili, Shyr, Yu, Lyman, Gary H., Warner, Jeremy L.
Foilsithe in Cancer Discov (2020)

Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies

le Bettegowda, Chetan, Sausen, Mark, Leary, Rebecca J., Kinde, Isaac, Wang, Yuxuan, Agrawal, Nishant, Bartlett, Bjarne R., Wang, Hao, Luber, Brandon, Alani, Rhoda M., Antonarakis, Emmanuel S., Azad, Nilofer S., Bardelli, Alberto, Brem, Henry, Cameron, John L., Lee, Clarence C., Fecher, Leslie A., Gallia, Gary L., Gibbs, Peter, Le, Dung, Giuntoli, Robert L., Goggins, Michael, Hogarty, Michael D., Holdhoff, Matthias, Hong, Seung-Mo, Jiao, Yuchen, Juhl, Hartmut H., Kim, Jenny J., Siravegna, Giulia, Laheru, Daniel A., Lauricella, Calogero, Lim, Michael, Lipson, Evan J., Marie, Suely Kazue Nagahashi, Netto, George J., Oliner, Kelly S., Olivi, Alessandro, Olsson, Louise, Riggins, Gregory J., Sartore-Bianchi, Andrea, Schmidt, Kerstin, Shih, le-Ming, Oba-Shinjo, Sueli Mieko, Siena, Salvatore, Theodorescu, Dan, Tie, Jeanne, Harkins, Timothy T., Veronese, Silvio, Wang, Tian-Li, Weingart, Jon D., Wolfgang, Christopher L., Wood, Laura D., Xing, Dongmei, Hruban, Ralph H., Wu, Jian, Allen, Peter J., Schmidt, C. Max, Choti, Michael A., Velculescu, Victor E., Kinzler, Kenneth W., Vogelstein, Bert, Papadopoulos, Nickolas, Diaz, Luis A.
Foilsithe 2014